NCT06054854Recruiting
Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Biobank for the Identification of Diagnostic, Prognostic or Therapeutic (Response and Resistance) Biomarkers in Lung Cancer (Early and Advanced Stages of Lung Cancer Cohort of the BIRD (Biomarkers in Respiratory Disease) Biobank)
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
The BIRD biobank aims at collecting clinical and biological data from patients suffering from a chronic respiratory disease. The lung cancer subpopulation will be divided into two cohorts to identify biomarkers of cancer. One cohort will include patients with supra-centimetric lung nodule(s) whether surveillance, bronchoscopic or radio-guided biopsy or surgery is indicated, patients suspected of lung cancers requiring diagnostic and/or therapeutic bronchial endoscopy and patients with a known early stage lung cancer (early-stage cohort). The second cohort will include known advanced stage lung cancers (III-IV).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 7 Sept 2023
- Start date
- 13 Jun 2024
- Primary completion date
- 1 Oct 2033
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Lung cancer
- NCT number
- NCT06054854
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 13 Jun 2024 to the primary completion date, 1 Oct 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient deprived of liberty on administrative or judicial decision, or patient under guardianship, curators or safeguard of justice
- Female patients who are pregnant or breastfeeding
Who the study is looking for
- Patients with 1 to 3 lung nodules including one \> 1 cm seen on chest CT
- OR: patients with suspected lung cancer requiring diagnostic and/or therapeutic bronchial endoscopy
- OR: Patient with histologically confirmed lung cancer, whether early stages prior to surgery, locally advanced or metastatic, included before the start of any anti-cancer treatment.
- Patient affiliated or beneficiary of a social security scheme
- Patients who are able to receive and understand information about the study and their participation and who have freely given their signed inform consent before any collection of samples or data necessary for the research (no restriction of rights by the judicial authorities and knowledge of the French language).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Larrey Hospital Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.